A new study found that primates that received just ONE vaccination containing thimerosal, the mercury-preservative found in many vaccines including the new swine flu shot, had significant neurological impairment when compared with those who received a saline solution injection or no injection at all.

Although the paper is carefully worded and the results reported modestly, these findings are certain to receive intense scrutiny. The vast majority of American infants born during the 1990's received a vaccine formulation similar to the one the thirteen vaccinated primates received.

Thimerosal-containing vaccines are still routinely administered to newborn infants in developing countries such as Brazil, and most influenza vaccines contain thimerosal and are routinely administered to pregnant women and infants.( And at 250X the safe dosage EPA "recommends", AND State of Washington took ALL Ceilings on Mercury!!!!!!) Tons of Autism, and retardartion will result!!!)

The finding that early exposure to potentially toxic vaccine formulations can cause significant neurodevelopmental delays in primates has explosive implications for vaccine safety management.

But while Americans are still debating whether to roll up their sleeves for a swine flu shot, companies have already figured it out: vaccines are good for business.

Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.